Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-18T00:18:41.489Z Has data issue: false hasContentIssue false
  • English
  • Français

Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects

Published online by Cambridge University Press:  16 April 2020

Alex Hofer ,
Susanne Baumgartner ,
Monika Edlinger ,
Martina Hummer ,
Georg Kemmler ,
Maria A. Rettenbacher ,
Hansjoerg Schweigkofler ,
Josef Schwitzer  and
W. Wolfgang Fleischhacker
Alex Hofer*
Affiliation:
Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A-6020Innsbruck, Austria
Susanne Baumgartner
Affiliation:
Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A-6020Innsbruck, Austria
Monika Edlinger
Affiliation:
Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A-6020Innsbruck, Austria
Martina Hummer
Affiliation:
Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A-6020Innsbruck, Austria
Georg Kemmler
Affiliation:
Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A-6020Innsbruck, Austria
Maria A. Rettenbacher
Affiliation:
Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A-6020Innsbruck, Austria
Hansjoerg Schweigkofler
Affiliation:
Department of General Psychiatry, General Hospital Bressanone, Bressanone, Italy
Josef Schwitzer
Affiliation:
Department of General Psychiatry, General Hospital Bressanone, Bressanone, Italy
W. Wolfgang Fleischhacker
Affiliation:
Department of Biological Psychiatry, Innsbruck Medical University, Anichstrasse 35, A-6020Innsbruck, Austria
*
*
Get access

Abstract

Objective

The present cross-sectional study examined the relationships of psychopathology, side effects, and sociodemographic factors with treatment outcomes in terms of patients' quality of life (QOL), functioning, and needs for care.

Method

Sixty outpatients with chronic schizophrenia who had been treated with either clozapine or olanzapine for at least 6 months were investigated.

Results

Most psychopathological symptoms as well as psychic side effects, weight gain, and female sex were associated with lower QOL, while cognitive symptoms correlated with better QOL. Female sex, cognitive symptoms, and parkinsonism negatively influenced occupational functioning, and negative symptoms determined a lesser likelihood of living independently. Age, education, depression/anxiety, negative symptoms, and psychic side effects were predictors of patients' needs for care.

Conclusion

Our results highlight the complex nature of patient outcomes in schizophrenia. They reemphasize the need of targeting effectiveness, i.e. both symptomatic improvement as well as drug safety, in such patients.

Keywords

SchizophreniaOutcomeNeedsQuality of lifeEmployment
Type
Original article
Information
European Psychiatry , Volume 20 , Issue 5-6 , August 2005 , pp. 386 - 394
Copyright
Copyright ©Elsevier SAS 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, J., Addington, D.Premorbid functioning, cognitive functioning, symptoms, and outcome in schizophrenia. J. Psychiatry Neurosci. 1993; 18: 18–23Google Scholar
Allison, D.B., Mackell, J.A., McDonnell, D.D.The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr. Serv. 2003; 54: 565–567CrossRefGoogle ScholarPubMed
Beiser, M., Bean, G., Erickson, D., Zhang, J., Iacono, W.G., Rector, N.A.Biological and psychosocial predictors of job performance following a first episode of psychosis. Am. J. Psychiatry 1994; 151: 857–863Google ScholarPubMed
Breier, A., Schreiber, J.L., Dyer, J., Pickar, D.National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch. Gen. Psychiatry 1991; 48: 239–246CrossRefGoogle ScholarPubMed
Brekke, J.S., Kohrt, B., Green, M.F.Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophr. Bull. 2001; 27: 697–708CrossRefGoogle Scholar
Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., et al.Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology, and tardive dyskinesia. Acta Psychiatr. Scand. 1996; 94: 118–124CrossRefGoogle ScholarPubMed
DeJong, A., Giel, R., Slooff, C.J., Wiersma, D.Relationship between symptomatology and social disability. Empirical evidence from a follow-up study of schizophrenic patients. Soc. Psychiatry 1986; 21: 200–205CrossRefGoogle ScholarPubMed
Dickerson, F., Boronow, J.J., Ringel, N., Parente, F.Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophr. Res. 1999; 37: 13–20CrossRefGoogle ScholarPubMed
Fleischhacker, W.W.Pharmacological treatment of schizophrenia: a review. Maj, M.Sartorius, N.Schizophrenia. WPA series evidence and experience in psychiatry Chichester, NY, Weinheim, Brisbane, Singapore, Toronto: Wiley; 2002 75–113Google Scholar
Fleischhacker, W.W., Rabinowitz, J., Kemmler, G., Lasser, R.A., Mehnert, A.Perceiving functioning, well-being and association with psychiatric symptomatology in clinically stable schizophrenia patients treated with long-acting risperidone for 1 year. Br. J. Psychiatry 2005[in press]CrossRefGoogle Scholar
Foldemo, A., Bogren, L.Need assessment and quality of life in outpatients with schizophrenia: a 5-year follow-up study. Scand. J. Caring Sci. 2002; 16: 393–398CrossRefGoogle ScholarPubMed
Hofer, A., Kemmler, G., Eder, U., Edlinger, M., Hummer, M., Fleischhacker, W.W.Quality of life in schizophrenia: the impact of psychopathology, drug attitude and side effects. J. Clin. Psychiatry 2004; 65: 932–939CrossRefGoogle ScholarPubMed
Hoffmann, K., Priebe, S.Welche Beduerfnisse nach Hilfe haben schizophrene Langzeitpatienten? Probleme der Selbst- und Fremdbeurteilung von “Needs”. Fortschr. Neurol. Psychiat. 1996; 64: 473–481CrossRefGoogle Scholar
Kallert, T.W., Leisse, M.Betreuungsbeduerfnisse schizophrener Patienten im Jahr nach Klinikentlassung in der Versorgungsregion Dresden. Fortschr. Neurol. Psychiat. 2000; 68: 176–187CrossRefGoogle Scholar
Kay, S.R., Fiszbein, A., Opler, L.A.The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987; 13: 261–276CrossRefGoogle Scholar
Kemmler, G., Holzner, B., Neudorfer, C., Meise, U., Hinterhuber, H.General life satisfaction and domain-specific quality of life in chronic schizophrenic patients. Qual. Life Res. 1997; 6: 265–273CrossRefGoogle ScholarPubMed
Lambert, M., Naber, D.Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 18Suppl 22004 5–17CrossRefGoogle ScholarPubMed
Lehman, A.F., Goldberg, R., Dixon, L.B., McNary, S., Postrado, L., Hackman, A., et al.Improving employment outcomes for persons with severe mental illnesses. Arch. Gen. Psychiatry 2002; 59: 165–172CrossRefGoogle ScholarPubMed
Leung, A., Chue, P.Sex differences in schizophrenia, a review of the literature. Acta Psychiatr. Scand. 2000; 101: 3–38CrossRefGoogle Scholar
Lindenmayer, J.P., Bernstein-Hyman, R., Grochowski, S.Five-factor model of schizophrenia. J. Nerv. Ment. Dis. 1994; 182: 631–638CrossRefGoogle ScholarPubMed
Lindenmayer, J.P., Grochowski, S., Hyman, R.B.Five factor model of schizophrenia: replication across samples. Schizophr. Res. 1995; 14: 229–234CrossRefGoogle ScholarPubMed
Lingjaerde, O., Ahlfors, U.G., Bech, P., Dencker, S.J., Elgen, K.The UKU Side Effect Rating Scale—a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. Suppl. 1987; 334: 1–100CrossRefGoogle Scholar
McGurk, S., Moriarty, P.J., Harvey, P.D., Parrella, M., White, L., Davis, K.L.The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophr. Res. 2000; 42: 47–55CrossRefGoogle ScholarPubMed
McGurk, S.R., Mueser, K.T.Cognitive functioning and employment in severe mental illness. J. Nerv. Ment. Dis. 2003; 191: 789–798CrossRefGoogle ScholarPubMed
Mercier, C., Peladeau, N., Tempier, R.Age, gender and quality of life. Community Ment. Health J. 1998; 34: 487–500CrossRefGoogle ScholarPubMed
Mueser, K.T.Cognitive functioning, social adjustment, and long-term outcome in schizophrenia. Sharma, T.Harvey, P.Cognition in schizophrenia New York NY: Oxford University Press; 2000.157–177Google Scholar
Mueser, K.T.Cognitive impairment, symptoms, social functioning, and vocational rehabilitation in schizophrenia. Kashima, H.Falloon, I.R.H.Mizuno, M.Asai, M.Comprehensive treatment of schizophrenia: linking neurobehavioral findings to psychosocial approaches Tokyo: Springer; 2002.344–351CrossRefGoogle Scholar
Norman, R.M., Malla, A.K.Correlations over time between dysphoric mood and symptomatology in schizophrenia. Compr. Psychiatry 1994; 35: 34–38CrossRefGoogle Scholar
Norman, R.M.G., Malla, A.K., McLean, T., Voruganti, L.P., Cortese, L., McIntosh, E., et al.The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr. Scand. 2000; 102: 303–309CrossRefGoogle ScholarPubMed
Ochoa, S., Haro, J.M., Autonell, J., Pendas, A., Teba, F., Marquez, M., et al.Met and unmet needs of schizophrenia patients in a Spanish sample. Schizophr. Bull. 2003; 29: 201–210CrossRefGoogle Scholar
Priebe, S., Heinze, M., Jäkel, A.Berliner Bedürfnis Inventar (BeBI). FU Berlin: Abteilung für Sozialpsychiatrie: 1993Google Scholar
Prudo, R., Monroe Blum, H.Five year outcome and prognosis in schizophrenia; a report from the London field centre of the international pilot study of schizophrenia. Br. J. Psychiatry 1987; 150: 345–354CrossRefGoogle ScholarPubMed
Racenstein, J.M., Harrow, M., Reed, R., Martin, E., Herbener, E., Penn, D.L.The relationship between positive symptoms and instrumental work functioning in schizophrenia: a 10 year follow-up study. Schizophr. Res. 2002; 56: 95–103CrossRefGoogle ScholarPubMed
Sartorius, N., Fleischhacker, W.W., Gjerris, U., Kern, U., Knapp, M., Leonhard, B.E., et al.The usefulness and use of second generation antipsychotic medications—an update. Curr. Opin. Psychiatry 16Suppl 12003 1–44Google Scholar
Slade, M., Thornicroft, G., Loftus, L., et al.CAN: The Camberwell Assessment of Need London: Gaskell; 1999Google Scholar
Swartz, M.S., Perkins, D.O., Stroup, T.S., McEvoy, J.P., Nieri, J.M., Haak, D.C.Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophr. Bull. 2003; 29: 33–43CrossRefGoogle ScholarPubMed
Thornicroft, G., Tansella, M., Becker, T., Knapp, M., Leese, M., Schene, A., et al.The personal impact of schizophrenia in Europe. Schizophr. Res. 2004; 69: 125–132CrossRefGoogle Scholar
The WHOQOL Group Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol. Med. 1998; 28: 551–558CrossRefGoogle Scholar
Voruganti, L.N.P., Heslegrave, R.J., Awad, A.G.Quality of life measurement during antipsychotic drug therapy of schizophrenia. J. Psychiatr. Neurosci. 1997; 22: 267–274Google ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.